Login Register Cart 0
Research Article

Characteristics of HIF-1Α and HSP70 MRNA Expression, Level, and Interleukins in Experimental Chronic Generalized Periodontitis

Author(s): Parkhomenko Daria, Belenichev Igor, Kuchkovskyi Oleh* and Ryzhenko Victor

Volume 13, Issue 2, 2024

Published on: 09 April, 2024

Page: [132 - 139] Pages: 8

DOI: 10.2174/0122115366264794240327073739

Price: $65

Abstract

Objectives: Periodontal diseases are a rather complex problem of modern dentistry and do not have only medical but also social significance.

The objective of this study is to weigh the effect of a mixture of Thiotriazoline and L-arginine (1:4) on the parameters of the system of endogenous cytoprotection of blood and periodontal illness in rats with experimental chronic generalized periodontitis and substantiate further study of this blend.

Materials and Methods: The study aimed to evaluate the impact of a combination of Thiotriazoline and L-arginine (in a ratio of 1:4) on the parameters of the endogenous blood cytoprotection system and periodontium in rats with experimental chronic generalized periodontitis. A group of outbred rats weighing 190-220 g and sourced from the vivarium of the Institute of Pharmacology and Toxicology of the Academy of Medical Sciences of Ukraine were divided into four groups, each consisting of 10 animals.

(1) Intact group, animals that were injected intragastrically with a solution of sodium chloride to chloride 0.9% for 30 days. (2) control, animals with experimental CGP who intragastrically sodium chloride solution 0.9% for 30 days. (3) animals with experimental CGP were injected intramuscularly with Thiotriazoline + L-arginine (1:4) in a dosage of 200 mg/kg (30 days). (4) animals with experimental CGP, for which daily intragastric reference drug Mexidol, in dosage 250 mg/kg (30 days).

In this study, we utilized two substances: Thiotriazoline and L-arginine hydrochloride. The combination of Thiotriazoline and L-arginine (in a ratio of 1:4) was prepared at the Department of Pharmaceutical Chemistry of ZSMU. At the conclusion of the experiment, the rats were carefully removed from the study while under thiopental-sodium anesthesia, and administered at a dosage of 40 mg/kg.

Results: We have found that the administration of a combined preparation of Thiotriazoline with L-arginine to rats with CGP leads to a significant decrease in the blood concentration of pro-inflammatory cytokines IL-1b and TNF-a by 56.1% and 71%, respectively.

Conclusion: The administration of Mexidol at a dosage of 250 mg/kg, as well as the combination of Thiotriazoline and Larginine in a ratio of 1:4 at a dosage of 200 mg/kg, resulted in a significant reduction in gingival pocket depth in animals with CGP. Specifically, the gingival pocket depth was reduced to 6 mm (p < 0.05) with Mexidol and further reduced to 4 mm (p < 0.05) with the combination of Thiotriazoline and L-arginine. Additionally, the animals exhibited minimal bleeding, swelling, and tooth mobility when treated with the combination of Thiotriazoline and L-arginine.

The administration of a combination of Thiotriazoline and L-arginine (in a ratio of 1:4) at a dosage of 200 mg/kg to animals with CGP resulted in a noteworthy reduction in the blood concentration of pro-inflammatory cytokines IL-1b and TNF-a. Specifically, there was a significant decrease of 56.1% (p < 0.05) in IL-1b and 71% (p < 0.05) in TNF-a levels. The course administration of a combination of Thiotriazoline and L-arginine (1:4) (200 mg/kg) to animals with CGP led to an increased expression of HSP70 mRNA (p < 0.05) in the periodontium by 8.2 times and HIF-1a mRNA by 8.2 times. 2.8 times (p < 0.05) against the background of an increase in the blood concentration of HSP70 by 95% (p < 0.05). Also, in the periodontium of animals in this group, a decrease in the expression of c-Fos mRNA by 36.7% (p < 0.05) was found compared to the control group.

Keywords: Periodontal tissues, thiotriazoline, l-arginine, nitroxidergic system, tiazotic acid, antioxidant activity, inflammation, CGP, mexidol.

« Previous Next »
Graphical Abstract

[1]
Nepomnyashhaya NV. Increasing the effectiveness of treatment of chronic generalized periodontitis (clinical and biochemical study). 2009. Available from: https://www.dissercat.com/content/povyshenie-effektivnosti-lecheniya-khronicheskogo-generalizovannogo-parodontita-klinoko-biok
[2]
Bobr IS. Comparative experimental clinical evaluation of a combination of the use of anti-hypoxanth, antioxidant and antiseptic agents in the complex treatment of inflammatory periodontal diseases in diabetes mellitus type 2 autophef.PhD, Moscow. 2009.
[3]
Kazarina LN, Vdovina LV, Dubrovskaia EN. Mexidol preparation influence upon lipids peroxide oxidation and oral fluid antioxidant system activity in patients with chronic generalized parodontitis and arterial hypertension. Stomatologia 2010; 89(2): 18-21.
[PMID: 20517245]
[4]
Samoylenko AV, Orishchenko VYu, Klimovich LA, et al. Medicines used in periodontology
[5]
Nemec A, Verstraete FJM, Jerin A, et al. Periodontal disease, periodontal treatment and systemic nitric oxide in dogs. Res Vet Sci 2013; 94(3): 542-4.
[http://dx.doi.org/10.1016/j.rvsc.2012.10.017] [PMID: 23158853]
[6]
Ongphichetmetha N, Lertpimonchai A, Champaiboon C. Bioactive glass and arginine dentifrices immediately relieved dentine hypersensitivity following non‐surgical periodontal therapy: A randomized controlled trial. J Periodontol 2022; 93(2): 248-57.
[http://dx.doi.org/10.1002/JPER.21-0091] [PMID: 34061357]
[7]
Bielenichev IF, Vizir VA, Mamchur VY, Kuriata OV. Place of thiotriazoline in the gallery of modern metabolitotropic medicines. Zaporozhye Med J 2019; 1: 118-28.
[8]
Bumbar ZO, Pinyazhko OR. The investigation of the combined application of thiotriazolin and urolesan in experimental periodontitis on the background of urolithiasis. Exper Clini Physiol Biochem 2017; 2017(4): 61-70.
[http://dx.doi.org/10.25040/ecpb2017.04.061]
[9]
Shchepanskiy BF. Pathophysiological mechanisms of the development of experimental bronchial asthma in chronic periodontitis and their correction with thiotriazolin: Abstract of the thesis. PhD
[10]
Regeda MS, Olekshiy PV, Kolishetska MA. Injecting the drug thiocetam on the destruction of the immune system of the blood of guinea pigs for the minds of the formation of experimental periodontitis and immobilization stress. Bullet Mar Med 2021; 4(93): 107-11.
[11]
Mir BAP, Samani MK. To the editor: Re: Arginine-nitric oxide-polyamine metabolism in periodontal disease. J Periodont 2012; 83(4): 393-4.
[12]
Kucherenko LI, Belenichev IF, Mazur IA, et al. Study of the cardioand endothelioprotective action of a new combined drug based on Larginine and thiotriazoline Pharmacol Drug Toxicol 2017; 1(52): 54-60.
[13]
Combined medicinal product with hepatoprotective, cardioprotective, placental protective, tocolytic and non-mimetic effects. 2016. Available from: https://uapatents.com/13-110597-kombinovanijj-likarskijj-zasib-gepatoprotektorno-kardioprotektorno-placentoprotektivno-tokolitichno-i-no-mimetichno-di.html
[14]
Kucherenko LI, Hromyleva OV, Mazur IA, Shishkina SV. Theoretical study about L-arginine complexes formation with thiotriazolin. Zaporozhye Med J 2017; 0(1): 108-12.
[http://dx.doi.org/10.14739/2310-1210.2017.1.91736]
[15]
Kuznetsov VM. Fundamentals of Scientific Research in Animal Husbandry. Kirov: Zonal Research Institute of Livestock Farming of the Northeast 2006.
[16]
Hirst JA, Howick J, Aronson JK, et al. The need for randomization in animal trials: an overview of systematic reviews. PLoS One 2014; 9(6): e98856.
[http://dx.doi.org/10.1371/journal.pone.0098856] [PMID: 24906117]
[17]
Parkhomenko D, Belenichev I, Bukhtiyarova N, et al. Pharmacocorrection of disturbances in the NO system in experimental chronic generalized periodontitis. Open Access Maced J Med Sci 2023; 11(A): 47-52.
[http://dx.doi.org/10.3889/oamjms.2023.10717]
[18]
Gorokhivskiy VN, Schneider SA, Tkachenko EK. Development of an experimental model of periodontitis. Innovat Dentist 2018; 1(17): 56-60.
[19]
Scott DA, Krauss J. Neutrophils in periodontal inflammation. Front Oral Biol 2012; 15: 56-83.
[20]
D’Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res 2010; 89(11): 1241-6.
[http://dx.doi.org/10.1177/0022034510375830] [PMID: 20739696]
[21]
Loukides S, Bakakos P, Kostikas K. Oxidative stress in patients with COPD. Curr Drug Targets 2011; 12(4): 469-77.
[22]
Tsai CC, Chen HS, Chen SL, et al. Lipid peroxidation: A possible role in the induction and progression of chronic periodontitis. J Periodontal Res 2005; 40(5): 378-84.
[http://dx.doi.org/10.1111/j.1600-0765.2005.00818.x] [PMID: 16105090]
[23]
Mazur I, Belenichev I, Kucherenko L, et al. Antihypertensive and cardioprotective effects of new compound 1-(β-phenylethyl)-4-amino-1,2,4-triazolium bromide (Hypertril). Eur J Pharmacol 2019; 853: 336-44.
[http://dx.doi.org/10.1016/j.ejphar.2019.04.013] [PMID: 30978321]
[24]
Culic C, Parvu AE, Alb SF, Alb C, Pop A. Effect of cimetidine on nitro-oxidative stress in a rat model of periodontitis. Clujul Med 2014; 87(3): 177-81.
[PMID: 26528020]
[25]
Boşca AB, Miclăuş V, Ilea A, et al. Role of nitro-oxidative stress in the pathogenesis of experimental rat periodontitis. Clujul Med 2016; 89(1): 150-9.
[PMID: 27004039]
[26]
Toczewska J, Konopka T, Zalewska A, Maciejczyk M. Nitrosative stress biomarkers in the non-stimulated and stimulated saliva, as well as gingival crevicular fluid of patients with periodontitis: Review and clinical study. Antioxidants 2020; 9(3): 259.
[http://dx.doi.org/10.3390/antiox9030259] [PMID: 32245286]
[27]
Parwani SR, Chitnis PJ, Parwani RN. Salivary nitric oxide levels in inflammatory periodontal disease – A case‐control and interventional study. Int J Dent Hyg 2012; 10(1): 67-73.
[http://dx.doi.org/10.1111/j.1601-5037.2011.00508.x] [PMID: 21564536]
[28]
Belenichev I, Gorbachova S, Pavlov S, Bukhtiyarova N, Puzyrenko A, Brek O. Neurochemical status of nitric oxide in the settings of the norm, an ischemic event of the central nervous system, and pharmacological bn intervention. Georgian Med News 2021; (315): 169-76.
[PMID: 34365445]
[29]
Belenichev IF, Aliyeva OG, Popazova OO, Bukhtiyarova NV. Involvement of heat shock proteins HSP70 in the mechanisms of endogenous neuroprotection: The prospect of using HSP70 modulators. Front Cell Neurosci 2023; 17: 1131683.
[http://dx.doi.org/10.3389/fncel.2023.1131683] [PMID: 37138769]
[30]
Rosenblum MD, Gratz IK, Paw JS, Lee K, Rothstein MA, Abbas AK. Response to self antigen imprints regulatory memory in tissues. Nature 2011; 480(7378): 538-42.
[http://dx.doi.org/10.1038/nature10664] [PMID: 22121024]
[31]
Borges TJ, Wieten L, van Herwijnen MJC, et al. The anti-inflammatory mechanisms of Hsp70. Front Immunol 2012; 3: 95.
[http://dx.doi.org/10.3389/fimmu.2012.00095] [PMID: 22566973]
[32]
Zhou L, Xue C, Chen Z, Jiang W, He S, Zhang X. c-Fos is a mechanosensor that regulates inflammatory responses and lung barrier dysfunction during ventilator-induced acute lung injury. BMC Pulm Med 2022; 22(1): 9.
[http://dx.doi.org/10.1186/s12890-021-01801-2]
[33]
Hop HT, Aryan LT, Huy TXN, Reyes AWB, Vu SH, Min WG. The key role of c-Fos for immune regulation and bacterial dissemination in Brucella infected macrophage. Front Cell Infect Microbiol 2018; 8: 287.
[http://dx.doi.org/10.3389/fcimb.2018.00287]
[34]
Belenichev I, Gorchakova N, Puzyrenko A, Kovalenko S, Bukhtiayrova N. Synthesis of the new 2-(3,4-dihydro-3-oxo-2h-[1,2,4]triazino[4,3-c]quinazolin -4-yl) acetic acid derivatives and analysis of their antioxidant activity in nitrosative stress models. Georgian Med News 2018; (280-281): 173-8.
[PMID: 30204120]
[35]
Belenichev IF, Shah F, Chekman IS, Nagornaya EA, Gorbacheva SV, Gorchakova NA. Thiol-disulfide system: Role in endogenous cyto-and organoprotection, pathways of pharmacological modulation LLC “Vydavnytstvo”. Kyiv: Yuston 2020.
[36]
Belenichev I, Kucherenko L, Pavlov S, et al. Therapy of post-COVID-19 syndrome: Improving the efficiency and safety of basic metabolic drug treatment with tiazotic acid (thiotriazoline). Pharmacia 2022; 69(2): 509-16.
[http://dx.doi.org/10.3897/pharmacia.69.e82596]
[37]
Burlaka BS, Belenichev IF, Ryzhenko OI, et al. The effect of intranasal administration of an IL-1b antagonist (RAIL) on the state of the nitroxydergic system of the brain during modeling of acute cerebrovascular accident. Pharmacia 2021; 68(3): 665-70.
[http://dx.doi.org/10.3897/pharmacia.68.e71243]
[38]
Belenichev IF, Mazur IA, Abramov AV, et al. The endothelium-protective effect of 3-methyl-1,2,4-triazolyl-5-thioacetate (S)-2,6-diaminohexanic acid (lysinium): Effects on the expression of vascular endothelial growth factor (VEGF) and the characteristics of the endotheliocytes of the cerebral vessels of animals with cerebral ischemia. Neurochem J 2013; 7(4): 296-302.
[http://dx.doi.org/10.1134/S181971241304003X]
[39]
Popazova O, Belenichev I, Yadlovskyi O, Oksenych V, Kamyshnyi A. Altered blood molecular markers of cardiovascular function in rats after intrauterine hypoxia and drug therapy. Curr Issues Mol Biol 2023; 45(11): 8704-15.
[http://dx.doi.org/10.3390/cimb45110547] [PMID: 37998724]
[40]
Belenichev IF, Voitenko DS, Bukhtiayrova NV. Reduce the neuroapoptosis in the brain of rats born to mothers with experimental placental insufficiency by combination of thiotriazoline with l-arginine and thiotriazolin with piracetam. Int J Neurorehabil 2019; 2019(6): 344.
[http://dx.doi.org/10.4172/2376-0281.1000344]
[41]
Belenichev IF, Kolesnik YM, Pavlov SV, Sokolik EP, Bukhtiyarova NV. Malate-aspartate shunt in neuronal adaptation to ischemic conditions: Molecular-biochemical mechanisms of activation and regulation. Neurochem J 2012; 6(1): 22-8.
[http://dx.doi.org/10.1134/S1819712412010023]
[42]
Shevchenko AO, Belenichev IF. Premature childbirth: Fundamental and clinical aspects: Monograph. LAP LAMBRET academic publishing 2022.
[43]
Belenichev IF, Cherny VI, Nagorna EA, Pavlov SV, Bukhtiyarova NV. Neuroprotection and neuroplasticity: Monograph. Kyiv: Logos 2015.
[44]
Chekman I, Belenichev I, Yakovleva I, et al. Influence of mexidol on early genomic response and morphofunctional parameters of brain cortex sensorimotor zone neurons after arteria carotis communis occlusion. Oxid Antioxid Med Sci 2015; 4(1): 33.
[http://dx.doi.org/10.5455/oams.090315.or.083]

Rights & Permissions Print Cite
Article Metrics
10
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy